RWC Update: Management of Persistent Peripheral Avascular Retina in Retinopathy of Prematurity Survivors; Giant Macular Hole Leading to a Total Retinal Detachment; Proliferative Sickle Cell Retinopathy: Intraoperative Fluorescein Angiography Guided Management

Hot Topic in the World of Retina Management of Persistent Peripheral Avascular Retina in Retinopathy of Prematurity Survivors Submitted by: M. Elizabeth Hartnett, MD, FACS; Şengül Özdek, MD, FEBO, FASRS; Anand Vinekar, MS, PhD, FRCS; Domenico Lepore, MD; Francesca Lepore, BS Peripheral persistent av...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ophthalmic surgery, lasers & imaging Jg. 56; H. 5; S. 259 - 261
Hauptverfasser: Sharma, Ashish, Wu, Lihteh, Bloom, Steven, Stanga, Paulo, Hartnett, M. Elizabeth, Özdek, Şengül, Vinekar, Anand, Lepore, Domenico, Lepore, Francesca, Temkar, Anand, Nagpal, Manish, Martínez, Eduardo, Rezaei, Kourous A.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Thorofare, NJ SLACK Incorporated 01.05.2025
Slack, Inc
SLACK INCORPORATED
Schlagworte:
Angiography
Babies
Fluorescein
Growth factors
Lasers
Medical imaging
Ophthalmology
Retina
Retinal detachment
Retrolental fibroplasia
Sickle cell anemia
Vascular endothelial growth factor
India
Rome Italy
Italy
ISSN:2325-8160, 2325-8179, 2325-8179
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hot Topic in the World of Retina Management of Persistent Peripheral Avascular Retina in Retinopathy of Prematurity Survivors Submitted by: M. Elizabeth Hartnett, MD, FACS; Şengül Özdek, MD, FEBO, FASRS; Anand Vinekar, MS, PhD, FRCS; Domenico Lepore, MD; Francesca Lepore, BS Peripheral persistent avascular retina (PPAR) is very common following regression of retinopathy of prematurity (ROP) either spontaneously or with anti-vascular endothelial growth factor (anti-VEGF) treatment.1,2 There is an ongoing debate about the management of PAR—whether it should be left alone or should be treated with laser photocoagulation (LPC). Socioeconomic factors, particularly in low-resource settings within low- and middle-income countries, further impede consistent follow-up.3 The KIDROP program, currently operational across 177 neonatal units in Karnataka, India, employs a tele-ROP model to mitigate these challenges. In centers with GA or in-patient facilities, follow-up may extend until 55–60 weeks PMA before laser treatment is performed under GA. Late prophylactic laser is considered by many experts worldwide when PAR persists beyond 60 weeks PMA, to avoid exhausting the families' capacity for long-term follow-up.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2325-8160
2325-8179
2325-8179
DOI:10.3928/23258160-20250412-01